AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-18254148_ITM" title="Facts and information about Amgen wins approval for Kepivance.">Amgen wins approval for Kepivance.</a>

Close Set up an RSS feed that alerts you when new articles from The America's Intelligence Wire are available.

Frequently asked questions about RSS feeds

Amgen wins approval for Kepivance.

The America's Intelligence Wire

| December 15, 2004 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From CBS Marketwatch (Stories))

BOSTON (CBS.MW) -- Amgen said late Wednesday that the Food and Drug Administration approved its drug to treat a painful condition associated with high-dose chemotherapy.

Amgen said that the FDA cleared Kepivance to be used in treating oral mucositis, mouth sores that are caused by…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


New England Journal of Medicine Publishes Phase III Results of VELCADE(R)...: Newspaper article from: Blood Weekly September 11, 2008 700+ words
...from the 682 patient, randomized, Phase III VISTA(1) trial in this week's edition of the New England Journal of Medicine. The results showed a...multiple myeloma on June 20, 2008. The Phase III VISTA trial was conducted by Millennium...


New England Journal of Medicine publishes Phase III results of Velcade...: News wire article from: Chemical Business Newsbase August 27, 2008 700+ words
...Co announced the publication of results from the 682 patient, randomised, Phase III VISTA(1) trial in Aug 2008 last week's edition of the New England Journal of Medicine. The results showed a significant survival benefit and a 30% complete...


InterMune Announces New England Journal of Medicine Publication of Phase III...: Press release article from: PR Newswire January 7, 2004 700+ words
...announced the publication, in The New England Journal of Medicine, of previously presented...blind, placebo-controlled Phase III trial (GIPF-001) evaluating...D., Senior Author of the New England Journal of Medicine publication, INSPIRE...


InterMune announces New England Journal of Medicine publication of Phase III...: News wire article from: Asia Africa Intelligence Wire January 7, 2004 700+ words
...InterMune Inc announced that New England Journal of Medicine has published...blind, placebo-controlled Phase III trial (GIPF-001) evaluating...placebo-controlled pivotal Phase III trial. The first patient...blind, placebo controlled Phase III clinical trial (GIPF-001...


Tysabri two-year Phase III multiple sclerosis clinical trial results and safety...: News wire article from: Chemical Business Newsbase March 1, 2006 700+ words
...year results from the two Phase III clinical trials evaluating...the first time in The New England Journal of Medicine. Two-Year AFFIRM Phase III monotherapy data showed...The two-year Sentinel Phase III data also demonstrated...


Pivotal Phase III Tarceva Study Published in the New England Journal of...: Press release article from: Business Wire July 13, 2005 700+ words
...today that The New England Journal of Medicine published...from the pivotal Phase III study showing...survival. "This Phase III study represents...published in The New England Journal of Medicine are...placebo-controlled Phase III trial of patients...


Shearwater Announces Publication of Pegasys(R) Phase III Trial Results in New...: Press release article from: PR Newswire December 7, 2000 700+ words
...two papers in the New England Journal of Medicine presenting the results of two Phase III clinical trials for Pegasys...describes the results of a Phase III trail with 531 patients...unmodified interferon. In the Phase III study, Pegasys was administered...


Shearwater Announces Publication of Pegasys Phase III Trial Results in New...: Press release article from: Business Wire December 7, 2000 700+ words
...two papers in the New England Journal of Medicine presenting the results of two Phase III clinical trials for Pegasys...describes the results of a Phase III trail with 531 patients...unmodified interferon. In the Phase III study, Pegasys was administered...


New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III...: Press release article from: PR Newswire October 4, 2006 700+ words
...randomized, controlled pivotal Phase III clinical trials of LUCENTIS...injection) in the New England Journal of Medicine. The published...acuity over time for the Phase III MARINA ("Study 1") and the Phase III ANCHOR ("Study 2...


PRESS RELEASE: Shearwater announces publication of Pegasys Phase III trial...: News wire article from: Chemical Business Newsbase December 11, 2000 700+ words
...publication of two papers in the New England Journal of Medicine presenting the results of two Phase III clinical trials for Pegasys (peginterferon...hepatitis C," describes the results of a Phase III trail with 531 patients comparing the...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: